GLP toxicology/tumorigenicity study, As2-/- mice, single IV ARSA-LV or mock HSPCs, 52 weeks post-dose
“Toxicology and tumorigenicity study in ARSA KO mice treated with ARSA-/- HSPCs transduced with ARSA.LV Vector”
✓ VerifiedFDA pharmacology/toxicology review, p. 15Source ↗